Solutions
Pricing
Log in
Teams
Get started
Log in
Get started
Untitled
CM
by
Christina McClary
·
0 views
·
Updated Jan 12, 2022
Share
Embed
Re-use content
Create your own
Chapters
00:00
Chapter 1
03:16
Chapter 2
05:40
Chapter 3
07:16
Chapter 4
09:23
Chapter 5
Audio Transcript
Auto-generated
00:01 - 00:03
Okay I'm back and I brought some friends.
00:03 - 00:07
We're gonna talk about affinity potency and efficacy.
00:07 - 00:11
Uh These guys are my three year old sons
00:11 - 00:13
collection of stuffed dogs.
00:13 - 00:16
He actually has paid more than this but this is how I can carry in my hands.
00:16 - 00:23
This is bo Brittany Wish and Murphy dog um affinity is the extent
00:23 - 00:27
at which a drug binds to the receptor at a certain concentration.
00:27 - 00:29
So how tightly
00:30 - 00:36
Does the drug bind to the receptor? Um out of these four dogs
00:37 - 00:38
Wish
00:39 - 00:42
has the greatest affinity for Reef. He loves Wish Wish.
00:42 - 00:46
I don't know because he's little or what but he goes everywhere with my son Reef.
00:46 - 00:48
Um He is attached to him at all times.
00:48 - 00:51
It was very hard for me not too hard for him not to bring him to school this morning.
00:51 - 00:54
So which binds very tightly to my son,
00:54 - 00:58
my three year old and is with him at all times as close as possible
00:59 - 01:01
if wishes dirty needs to go in the wash.
01:01 - 01:03
Um He has other friends that he can hang
01:03 - 01:06
out with but which has the strongest affinity.
01:06 - 01:09
Um For reef, Reef has the strongest affinity for Wish actually.
01:09 - 01:14
But okay so these are usually shown in dissociation constant.
01:14 - 01:18
KD sometimes shown as K. I don't get hung up on K. D.
01:18 - 01:22
Or hang on their very similar ones more broad ones more specific. So if you see K. D.
01:22 - 01:30
Or K. I just know that they're inversely related to the affinity. So a lower
01:30 - 01:38
K. D. Or K. I means a higher affinity or stronger bond to the receptor
01:39 - 01:44
and a higher K. D. Or K. I. Has a lower affinity to the receptor.
01:44 - 01:47
So and a good example of this that we're going to keep coming back to
01:47 - 01:51
because I think it's just such a great real life example is the button orphan.
01:51 - 01:54
buprenorphine has a stronger affinity for the
01:54 - 01:57
opiate receptors than mu receptors than morphine.
01:57 - 02:00
So if you're giving it in the presence of morphine,
02:00 - 02:03
morphine is not going to be able to get to the receptors because buprenorphine
02:03 - 02:07
is going to get there faster stronger and stick and knock it off.
02:07 - 02:11
So the morphine is not gonna be able to
02:11 - 02:13
kick the buprenorphine off with the beauty of this an
02:13 - 02:15
opiate treatment is is that you're not going to have
02:15 - 02:19
that full response because buprenorphine is a partial agonist.
02:19 - 02:23
Um But it will stay on the receptors so that opiates will not be
02:23 - 02:26
able to find or you're like OxyContin or whatever you end up taking.
02:26 - 02:31
So below is some examples of some K. D. S. Or K. I. S.
02:31 - 02:35
I guess for these different opiates but one orphan is 10.221 point seven.
02:35 - 02:41
So remember the lower the K. Ii the stronger the affinity fentaNYL is 70.7 to 1.9.
02:41 - 02:43
So if you put fentaNYL in the presence of
02:43 - 02:45
an orphan that's going to be a
02:46 - 02:50
that's going to be a match right there on which one is going to activate the receptors
02:50 - 02:53
it could be probably either they're very similar um
02:53 - 02:56
morphine is 1.2 to 4 and then codeine.
02:56 - 02:59
If you put codeine in the presence of buprenorphine, codeine has no chance.
02:59 - 03:03
It's definitely not going to win that battle. Uh 65 to 1 35.
03:03 - 03:06
So you can see there that the
03:06 - 03:07
K. I.
03:07 - 03:10
Goes up the chances of it competing with the button orphan
03:10 - 03:14
for the receptors is lower and lower and no chance,
03:14 - 03:14
you know.
03:18 - 03:22
So efficacy is the ability to reach the max response.
03:22 - 03:26
So all of my buddies in my hand right here have the same efficacy.
03:26 - 03:30
They all can cause when and when they're individually given to reef.
03:30 - 03:35
He will love them equally when he has them if that's the only one that he has now this
03:35 - 03:36
this is salty dog,
03:37 - 03:39
this is Noelle's dog, this is my daughter's dog.
03:40 - 03:40
So
03:44 - 03:48
he likes salty dog but salty dog will never
03:48 - 03:51
be as effective as one of these guys because
03:51 - 03:56
it's not his it's his sister's dog and he just he's just not as cuddly and he said I
03:56 - 03:57
don't love him as much. So poor.
03:57 - 04:03
Salty dog is definitely just not as effective as bo Brittany wish and Murphy are
04:03 - 04:08
um you can see here in the graph B is showing the effectiveness
04:08 - 04:11
of this drug like what's the max effectiveness usually done as a max.
04:11 - 04:16
What is the max effectiveness? Okay, potency as we showed in that graph earlier.
04:16 - 04:21
Um like an espresso is more potent than a cup of folders or whatever.
04:21 - 04:26
Um This is how much of the drug you need to produce a response. This is a comparative
04:27 - 04:34
term. So drug A. On our slide there is more potent than drug B. You need less of drug A.
04:34 - 04:39
To produce a response than you need of drug B. So it is a relative term.
04:39 - 04:44
Um For example, fentaNYL is more potent than morphine. 50 times more potent.
04:45 - 04:49
When we're trying to convert opiate doses, we're going to use our mm. E.
04:49 - 04:53
Which you'll see very often is the morphine milligram equivalent.
04:53 - 04:57
So if you're trying to get them from like for example last month was a nightmare.
04:58 - 05:00
oxyCODONE. 15 was on backorder. oxyCODONE.
05:00 - 05:04
30 was basically all the oxyCODONE products were on back order was a nightmare.
05:04 - 05:09
So a lot of the doctors had to switch them to HYDROmorphone or morphine or
05:10 - 05:13
HYDROcodone or something else that I had.
05:13 - 05:18
That uh we could give them just for the month until that darn shortage was ending.
05:18 - 05:22
So how do you convert somebody from oxyCODONE to HYDROmorphone?
05:22 - 05:25
You're going to use the morphine milligram equivalent to
05:25 - 05:28
see how much HYDROmorphone you would need two.
05:28 - 05:31
You can convert it to the morphine and then convert it to the oxyCODONE.
05:31 - 05:33
So how much would you need to do that conversion there.
05:33 - 05:38
Um that is used in clinical real life on the rag. You'll use it.
05:38 - 05:40
So good to know that that's there and it exists.
05:42 - 05:44
Alright we're gonna get rid of our dogs
05:45 - 05:47
up regulation and down regulation.
05:47 - 05:51
So down regulation is a decreased number of receptors that are available.
05:51 - 05:57
So you actually going to need more of a drug to produce the same response over time.
05:57 - 06:00
Um opiates do this so over time you may need more opiates.
06:00 - 06:05
Um I used to have a couple girls that had sickle cell and
06:05 - 06:08
they have been on opiates since they were six years old unfortunately.
06:08 - 06:11
Um So by the time they were in their thirties they were
06:11 - 06:15
on these insanely dangerous doses of opiates that would kill anybody else.
06:15 - 06:17
But they were so tolerant to it,
06:17 - 06:20
this is not good this picture. Oh sorry
06:20 - 06:26
there um they were so tolerant to it that it didn't it didn't affect them in any way.
06:26 - 06:28
And a lot of pharmacists you know it's kind of sad because a
06:28 - 06:30
lot of pharmacist wouldn't fill medications for
06:30 - 06:33
them because these doses were lethal.
06:33 - 06:36
They were lethal doses but for them
06:36 - 06:38
they weren't lethal because their receptors have
06:38 - 06:41
been so down regulated because they had been on them for so long.
06:41 - 06:45
Uh The cannabinoid receptors are known for doing this and insulin receptors are
06:45 - 06:48
known for doing this so we're gonna need more insulin over time.
06:48 - 06:48
Also
06:48 - 06:53
now up regulation would be if the body produces more receptors over time.
06:53 - 06:56
So this happens in the third trimester of pregnancy.
06:56 - 06:59
Your body starts producing more oxytocin receptors and
06:59 - 07:01
preparation for that birth so that we can have
07:01 - 07:05
those strong contractions there um And everything we
07:05 - 07:06
need for breastfeeding and that sort of thing.
07:06 - 07:08
So you can see in this little picture here
07:08 - 07:11
the up regulation more receptors are produced by those
07:11 - 07:14
little blue ones and then down the bottom those
07:14 - 07:17
that down regulations as less receptors are produced.
07:18 - 07:21
Selectivity versus specificity.
07:22 - 07:28
Selectivity is the ability to bind to one subtype versus another subtype.
07:28 - 07:33
So as we get to our next lecture on tomorrow we will see that there's very
07:33 - 07:36
many Colin ergic subtypes um for the muscular
07:36 - 07:38
neck and then yeah you have the nicotine
07:38 - 07:41
and the most moronic and one of them has five subtypes and
07:41 - 07:46
the other one I was like three or whatever and you can
07:46 - 07:48
you bind to one of those subtypes that only is in like
07:48 - 07:53
two places in the body versus non selectively binding to the muscular
07:54 - 07:55
receptors in general and then you're going to
07:55 - 07:57
activate all the receptors all over the body.
07:57 - 08:01
Or can you do just the one receptor that works on the glands or whatever.
08:01 - 08:03
Um We'll talk about that more tomorrow.
08:04 - 08:06
So it likes to buy into one subtype of receptors.
08:06 - 08:10
So vera's veranda milk is a calcium channel blocker. It is an
08:10 - 08:12
antagonists of the calcium channels.
08:12 - 08:15
Um That's why it's in the class of
08:15 - 08:20
calcium channel blockers along with um loaded pine and
08:21 - 08:23
there's a bunch of them in there but at high doses it
08:23 - 08:26
can also block the sodium channels now it doesn't normally block the
08:26 - 08:29
sodium channels and it doesn't like to block the sodium channels but
08:29 - 08:32
if you give enough wrapping millet will block the sodium channels also.
08:32 - 08:36
But I want you to note that verapamil is technically a calcium channel blocker.
08:36 - 08:40
Okay then specificity specificity is the ability to
08:40 - 08:42
buy into just one type of receptor.
08:42 - 08:46
So our best friend from last week atropine
08:46 - 08:49
binds to the acetylcholine receptors but it's non
08:49 - 08:52
selective so it binds to all the acetylcholine
08:52 - 08:55
receptors causing a wide variety of responses.
08:55 - 08:56
Can we name them?
08:57 - 09:01
Blind as a bat mad as a hatter dry as a bone ridges beat
09:03 - 09:05
was I always forget that last one
09:07 - 09:09
tachycardia and there's one more.
09:09 - 09:12
Um but it's going to produce a wide variety
09:12 - 09:16
of um responses throughout the entire body because it is
09:17 - 09:20
I'm going to activate all types of acetylcholine
09:20 - 09:23
receptors and not just one subtype versus another.
09:26 - 09:29
Synergism versus additive additive effects.
09:29 - 09:33
Now this is a little bit tricky when I was looking up different examples of these.
09:33 - 09:34
They're kind of all over the place.
09:34 - 09:36
I think it's very difficult to tell if something
09:36 - 09:41
is synergistic versus additive additive means if you take
09:42 - 09:44
one drug like
09:45 - 09:47
Aspirin and one drug like Tylenol.
09:49 - 09:51
The aspirin is gonna cause blood thinning effect.
09:51 - 09:54
And the talent I was gonna fight cause pain reliever and you take them together,
09:54 - 09:58
you're gonna have blood thinning pain relief basically one plus one equals two.
09:58 - 10:04
Um synergism is one plus one equals three. So that means that you take to drugs.
10:04 - 10:08
So they one of them had to use an example of aspen causing 30% blood
10:08 - 10:11
thinning and Plavix causing 30% blood thinning and
10:11 - 10:14
then together they cost 90% blood thinning.
10:14 - 10:16
So one plus one equals three so that
10:16 - 10:18
some of both of them together causes an
10:18 - 10:23
amplified response more than just the additive effect
10:23 - 10:25
important to know but not that important.
10:25 - 10:27
I mean you'll see this a lot if you're giving
10:27 - 10:31
like an opiate plus a benzo plus muscle relaxant,
10:32 - 10:33
you know that sort of thing.
10:33 - 10:36
So just know that that's the thing where you can have these
10:36 - 10:38
drug interactions where they combine and
10:38 - 10:42
produce produce an increase amplified effect.
10:42 - 10:43
Um
10:44 - 10:45
Okay,
10:45 - 10:47
I think that's all I have for you guys for pharma
10:47 - 10:50
code dynamics today I will start getting you some kinetics out and
10:51 - 10:53
and then we'll get started on that one and
10:53 - 10:57
understand now what the body does to the drug.
10:57 - 10:58
And I will see you tomorrow.
10:58 - 11:01
I will be there at noon if anybody wants to come a little early and talk to
11:01 - 11:04
me and we'll do a little bit of reviewing on this um while we're in class.
11:04 - 11:07
Okay you guys have a great day. Bye.
See full transcript